Primary fallopian tube carcinoma is the least common of the gynecological malignancies and rarely diagnosed preoperatively. We report the case of a 70-year-old woman with primary tubal carcinoma, which was diagnosed preoperatively on the basis of elevated CA125 and characteristic features found by transvaginal sonography, transvaginal color flow imaging and magnetic resonance imaging. Transvaginal ultrasonography showed a sausage-shaped solid mass alongside the right ovary. Transvaginal color Doppler imaging revealed characteristically low impedance vascular flow within the solid components. A pathohistological study confirmed the diagnosis of fallopian tube carcinoma. [Tzu Chi Med J 2010;22(4): 225-228] 
Introduction
Primary adenocarcinoma of the fallopian tube comprises only 0.3% of all gynecological cancers [1] . In many patients, fallopian tube carcinoma is asymptomatic. A definite preoperative diagnosis of fallopian tube cancer is made in only 3-15% of patients, and the usual clinical diagnosis is an ovarian tumor or pelvic inflammatory disease [1] [2] [3] [4] . The aim of this paper is to discuss the clinical presentation, transvaginal sonography results and magnetic resonance imaging (MRI) features of fallopian tube carcinoma as well as the role of the tumor marker CA125 in its diagnosis. Furthermore, we assess the response and follow-up to the postsurgical treatment and chemotherapy of the epithelial ovarian cancer.
Case report
A 70-year-old, gravida 4, para 4, woman came to our hospital due to a dull pain over her right lower abdomen, but no serosanguineous vaginal discharge or postmenopausal bleeding. Pap smear was normal.
Transvaginal ultrasonography showed a sausageshaped solid mass measuring 7 × 3 cm alongside the right ovary. Doppler flow indicated a flow with a resistance index of 0.33 (Fig. 1) . The patient's CA125 antigen level was 173 U/mL. MRI of the whole abdomen with and without contrast enhancement revealed a tubular tumor mass (7.99 × 2.89 cm) in the right pelvic cavity r/o salpinx tumor, unremarkable changes to the liver, spleen and pancreas, no enlarged lymph nodes in the pelvic and para-aortic regions and no ascites (Fig. 2) . She underwent total hysterectomy, bilateral salpingo-oophorectomy, infracolic omentectomy, and pelvic and para-aortic lymph node sampling. No macroscopic disease was left following the operation. Microscopically, sections of right fallopian tube and ovary showed the presence of moderately differentiated adenocarcinoma that was characterized by crowded complex branching neoplastic glands with a cribriform to glandular architecture or back-to-back glands without intervening stroma. The tumor cells exhibited dot-like nucleoli within hyperchromatic nuclei with mild to moderate pleomorphism, coarse chromatin and mild mitotic figures. The serosal layers were unremarkable (Fig. 3 ). There were no metastatic tumors in the pelvic and para-aortic lymph nodes, and the abdominal cytology was negative. The FIGO stage was assessed to be stage IIA.
Two months later, the patient was treated with six courses of adjuvant chemotherapy including taxol/ cisplatin chemotherapy. CA125 decreased to a normal level after two courses of chemotherapy. One year after the operation, MRI revealed no evidence of recurrence and CA125 levels remained normal. The patient continues to receive regular follow-up at our hospital.
Discussion
The most common presentation of fallopian tube cancer is vaginal bleeding and discharge (50-60%) followed by abdominal pain (30-49%) and abdominal mass (12-61%) [1] [2] [3] [4] . Abdominal pain can be colicky (as a result of forced tubal peristalsis) or dull (as a result of tube distension). Latzko's triad of symptoms, consisting of intermittent profuse serosanguineous vaginal discharge, colicky pain relieved by discharge, and an abdominal or pelvic mass, is reported in only 15% of patients [2] [3] [4] . Most patients have a delay in diagnosis, and early clinical suspicion helps early diagnosis. In our case, the patient presented only with right lower abdominal dull pain but did not have serosanguineous vaginal discharge or postmenopausal bleeding. A pap smear was normal. The sonographic appearance of fallopian tube carcinoma can be nonspecific and may mimic other pelvic diseases such as tubo-ovarian abscess, ovarian tumor, and ectopic pregnancy. Reported features include a sausage-shaped mass, cystic spaces with mural nodules and a multilobular mass with a cog and wheel appearance in the adnexal region [5] [6] [7] [8] . Low impedance vascular flow within the solid components has been observed in some cases [5] [6] [7] [8] . In our case, transvaginal ultrasonography showed a sausage-shaped solid mass measuring 7 × 3 cm alongside the right ovary. Doppler flow showed low vascular impedance with a resistance index of 0.33. With both computed tomography (CT) and MRI, the lesion can appear relatively solid, and lobulated when not associated with hydrosalpinx. Associated CT and MRI findings include peritumoral ascites, intrauterine fluid collection, and hydrosalpinx [9, 10] . Importantly, MRI is superior to CT and ultrasound when identifying local tumor infiltration of the bladder, pelvic fat, vagina, pelvic sidewalls, and bowel [9, 10] .
Serum CA125 is used routinely as a tumor marker for diagnosis, assessing response to treatment and follow-up of epithelial ovarian cancer. Although CA125 is not diagnostic of fallopian tube cancer, more than 80% patients have elevated pretreatment serum CA125 levels and 87% of tumor tissues stain positively for CA125 [11, 12] . Pretreatment serum CA125 level is an independent prognostic factor of disease-free status and overall survival in patients with fallopian tube cancer. If elevated, serum CA125 level also adequately defines the response to chemotherapy [11, 12] . In 90% of patients, an increase in serum CA125 level precedes clinical or radiological diagnosis of recurrent disease with a median lead time of 3 months (range, 0.5-7 months) [11, 12] . In our case, the patient had an elevated pretreatment serum CA125 level of 173 U/mL, which decreased to a normal level after two courses of chemotherapy. One year postoperatively, her CA125 levels remain normal.
The diagnosis of fallopian tube carcinoma is not often made preoperatively and may not be made even on initial surgery. This means that correct staging may not be performed at the time of the initial operation. In advanced disease, postoperative residual disease larger than 2 cm can have an adverse prognostic impact [13] [14] [15] [16] . Aggressive debulking should be attempted in patients with an advanced tumor. Surgery should consist of bilateral salpingooophorectomy, total abdominal hysterectomy, and comprehensive surgical staging [13] [14] [15] [16] . Patients with advanced disease should undergo paclitaxelcontaining regimens, including cisplatin/carboplatin and a standard combination of cyclophosphamide, adriamycin, and platinum (CAP) chemotherapies [17] [18] [19] [20] [21] [22] . Our patient underwent total hysterectomy, bilateral salpingo-oophorectomy, infracolic omentectomy, and pelvic lymph node and para-aortic sampling. No macroscopic disease was left following the operation. There were no metastatic tumors present in the pelvic and para-aortic lymph nodes and the abdominal cytology was negative. The FIGO stage was assessed to be stage IIA. Two months later, the patient was treated by adjuvant chemotherapy including cisplatin/taxol chemotherapy, and CA125 decreased to a normal level after two courses of chemotherapy.
In summary, primary carcinoma of the fallopian tube can be strongly suspected preoperatively on the basis of its characteristic clinical symptoms, an elevated CA125 level, a transvaginal sonographic investigation, and MRI findings.
